Trials / Conditions / Metastatic Kidney Medullary Carcinoma
Metastatic Kidney Medullary Carcinoma
3 registered clinical trials studyying Metastatic Kidney Medullary Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted NCT03866382 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer NCT03587662 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic NCT02721732 | M.D. Anderson Cancer Center | Phase 2 |